Expertise in
5
conditions

Dr. Kathleen Flint

Rheumatology
Columbia Arthritis Center PA
1711 Saint Julian Pl, 
Columbia, SC 
44 Years of Experience
Expertise in
5
conditions
Columbia Arthritis Center PA
1711 Saint Julian Pl, 
Columbia, SC 

Overview

Kathleen Flint is a Rheumatologist practicing medicine in Columbia, South Carolina. She has been practicing medicine for over 44 years.

Dr. Flint is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Eosinophilia-Myalgia Syndrome.

She is actively involved in clinical research, participating in 6 clinical trials.

Graduate Year

1982

Specialties

Rheumatology

Licenses

Internal Medicine in SC

Hospital Affiliations

Newberry County Memorial Hospital
Prisma Health Baptist Parkridge

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Columbia Arthritis Center PA
1711 Saint Julian Pl, Columbia, SC 29204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: March 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
23
conditions
Dr. Bruce Goeckeritz
Rheumatology
Expertise in
23
conditions
Dr. Bruce Goeckeritz
Rheumatology

Office

146 E Hospital Dr Ste 550, 
West Columbia, SC 
 (5.6 miles away)
803-936-7410
Languages Spoken:
English
See accepted insurances

Bruce Goeckeritz is a Rheumatologist practicing medicine in West Columbia, South Carolina. Dr. Goeckeritz is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Juvenile Temporal Arteritis, Giant Cell Arteritis (GCA), and Temporal Arteritis.

Expertise in
9
conditions
Dr. Fernando Castro
Rheumatology
Expertise in
9
conditions
Dr. Fernando Castro
Rheumatology

Office

146 N Hospital Dr Ste 550, 
West Columbia, SC 
 (6.5 miles away)
803-936-7410
Languages Spoken:
English
See accepted insurances

Fernando Castro is a Rheumatologist practicing medicine in West Columbia, South Carolina. Dr. Castro is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis, Sjogren Syndrome, and Undifferentiated Connective Tissue Disease (UCTD).

Expertise in
19
conditions
Dr. Janie K. Bruce
Rheumatology
Expertise in
19
conditions
Dr. Janie K. Bruce
Rheumatology

MUSC Health Rheumatology Elgin Medical Pavilion

40 Pinnacle Parkway, Suite 208, 
Elgin, SC 
 (16.9 miles away)
803-424-5750
Languages Spoken:
English
See accepted insurances
Accepting New Patients

A South Carolina native, Dr. Bruce graduated with a bachelor's degree from Wofford College in Spartanburg, S.C., and earned her medical degree from the University of South Carolina School of Medicine. She completed her residency at Palmetto Health Richland and Dorn VA Medical Center and spent a year practicing hospitalist medicine.Dr. Bruce is board-certified in internal medicine by the American Board of Internal Medicine and has been a member of the American Medical Association since 2003. She treats many diseases, including auto-immune disorders, osteoarthritis, osteoporosis, and rheumatoid arthritis. She enjoys helping patients debilitated by their disease return to being able to do everyday functions. She hopes her patients see her as someone they can relate to and feel comfortable with. Dr. Bruce is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Dermatomyositis, Necrotizing Vasculitis, and Sjogren Syndrome. Dr. Bruce is currently accepting new patients.

Frequently Asked Questions about Dr. Kathleen Flint

How do I make an appointment with Dr. Kathleen Flint?

You can book an appointment with Dr. Kathleen Flint by calling their office at 803-779-0911. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kathleen Flint a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kathleen Flint is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kathleen Flint specialize in?

While Dr. Kathleen Flint is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Psoriatic Arthritis, and Psoriasis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Kathleen Flint accept my insurance?

Dr. Kathleen Flint accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 803-779-0911 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Flint's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile